Search

Search Constraints

You searched for: Author/Creator Mulcahy, Mary

Search Results

1. 374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors. (10th December 2020)

2. 374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors. (9th November 2020)

3. E4206: AMG 706 and Octreotide in Patients with Low‐Grade Neuroendocrine Tumors. (31st May 2018)

5. Low rates of predominant breastfeeding in hospital after gestational diabetes, particularly among Indigenous women in Australia. (22nd January 2017)

7. Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. Issue 5 (6th November 2012)

8. Radiological‐pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib. Issue 5 (1st October 2013)

9. Radiological‐pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib. Issue 5 (1st October 2013)

10. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology‐pathology correlation and survival of radiation segmentectomy. Issue 1 (27th May 2014)